2019

Scientific Articles

unige:130219	Faut-il prescrire plus d’inhibiteurs SGLT-2 ?	Philippe, Jacques; Jornayvaz, François;
unige:130218	Insuffisance rénale chronique et nouveaux traitements antidiabétiques : tour d’horizon en 2019	Andrade Lopes, Stéphanie; Jornayvaz, François; De Seigneux Matthey, Sophie;
unige:130012	Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism	Montandon, Sophie; Somm, Emmanuel; Loizides-Mangold, Ursula; De Vito, Claudio; ... Jornayvaz, François
unige:133027	Nonalcoholic fatty liver disease burden	Goossens, Nicolas; Bellentani, Stefano; Cerny, Andreas; Dufour, Jean-François; ... Semela, David
unige:130217	Salivary cortisol is not associated with incident insulin resistance or type 2 diabetes mellitus	Gariani, Karim; Marques-Vidal, Pedro; Waeber, Gérard; Vollenweider, Peter; Jornayvaz, François
unige:130216	Thirteen-year trends in the prevalence of diabetes in an urban region of Switzerland: a population-based study	De Mestral, Carlos; Stringhini, Silvia; Guessous, Idris; Jornayvaz, François;
unige:130220	[News in diabetology 2018]	Jornayvaz, François;

2018

Scientific Articles

unige:109607	An Overview on Diabetic Foot Infections, including Issues Related to Associated Pain, Hyperglycemia and Limb Ischemia	Uckay, Ilker; Jornayvaz, François; Lebowitz, Dan; Gastaldi, Giacomo Gianni Giuseppe; ... Lipsky, Benjamin Alan
unige:111653	Consequences of the Adoption of the IADPSG versus Carpenter and Coustan Criteria to Diagnose Gestational Diabetes: A Before-After Comparison	Gariani, Karim; Egloff, Michaël; Prati, Sarah; Philippe, Jacques; ... Jornayvaz, François
unige:108916	Diabète de type 1, activité physique et nouvelles technologies	Kosinski, Christophe; Le Dizès, Olivier; Gastaldi, Giacomo; Andrey, Magali; ... Puder, Jardena J
unige:109400	Diabète prégestationnel : une entité de plus en plus fréquente	Gariani, Karim; Ditisheim, Agnès; Boulvain, Michel; Jornayvaz, François;
unige:109394	Diabétologie	Jornayvaz, François;
unige:108915	Fibroblast Growth Factor 15/19 - From Basic Functions to Therapeutic Perspectives	Somm, Emmanuel; Jornayvaz, François;
unige:109629	Observance thérapeutique et empilage médicamenteux	Jornayvaz, François; Philippe, Jacques;
unige:109403	Prise en charge de la dyslipidémie chez les patients avec un diabète de type 1	Andrade Lopes, Stéphanie; Fumani, Célia; Jornayvaz, François; Philippe, Jacques; Gastaldi, Giacomo
unige:109396	Transition optimale hôpital-domicile d’un patient diabétique de type 2 : quelques outils	Hafner, Catherine; Jornayvaz, François;

2017

Scientific Articles

unige:109655	AMPK activation caused by reduced liver lactate metabolism protects against hepatic steatosis in MCT1 haploinsufficient mice	Carneiro, Lionel; Asrih, Mohamed; Repond, Cendrine; Sempoux, Christine; ... Pellerin, Luc
unige:109630	Diabète sucré secondaire à une endocrinopathie : quand y penser ?	Rouiller, Nathalie; Jornayvaz, François;
unige:99474	Diabétologie	Jornayvaz, François;
unige:109623	Diètes cétogènes : la solution miracle ?	Kosinski, Christophe; Jornayvaz, François;
unige:100540	Effects of Antidiabetic Drugs on Gut Microbiota Composition	Montandon, Sophie; Jornayvaz, François;
unige:98426	GPR40 mediates potential positive effects of a saturated fatty acid enriched diet on bone	Philippe, Claire; Wauquier, Fabien; Landrier, Jean-François; Bonnet, Lauriane; ... Wittrant, Yohann
unige:100722	Grip strength is not associated with incident type 2 diabetes mellitus in healthy adults: The CoLaus study	Marques-Vidal, Pedro; Vollenweider, Peter; Waeber, Gérard; Jornayvaz, François;
unige:111063	Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples	Jornayvaz, François; Philippe, Jacques; Perez-Andres, Martin; Martin-Ayuso, Marta; ... Orfao, Alberto
unige:109612	Traitement du diabète: quand faire appel au diabétologue?	Jornayvaz, François; Philippe, Jacques;
unige:100523	Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease	Goossens, Nicolas; Jornayvaz, François;
unige:109609	Treatment challenges in type 1 diabetes after roux-en-Y gastric bypass	Favre, Lucie; Pralong, François Pierre; Suter, Michel; Jornayvaz, François;
unige:109653	Use of Dipeptidyl-Peptidase IV Inhibitors and Bullous Pemphigoid	Schaffer, Clara; Buclin, Thierry; Jornayvaz, François; Cazzaniga, Simone; ... Feldmeyer, Laurence
unige:109617	Utilité de la mesure en continu de la glycémie chez les patients diabétiques de type 2	Corcillo, Antonella; Girardin, Sylvie; Andrey, Magali Caroline; Le Dizès, Olivier; Jornayvaz, François
unige:98425	β-Klotho deficiency protects against obesity through a crosstalk between liver, microbiota, and brown adipose tissue	Somm, Emmanuel; Henry, Hugues; Bruce, Stephen J; Aeby, Sébastien; ... Pitteloud, Nelly

Professional Articles

unige:109611

Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies

Kosinski, Christophe; Jornayvaz, François;

2016

Scientific Articles

unige:89810	Comment faire pour prévenir le diabète de type 2 en Suisse?	Philippe, Jacques; Jornayvaz, François;
unige:96960	Diabète gestationnel – quelles sont les approches non médicales ?	Horsch, Antje; Gross, Justine; Jornayvaz, François; Lanzi, Stefano; Puder, Jardena J
unige:96958	Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection	Brinck, Jonas; Thomas, Aurélien; Lauer, Estelle; Jornayvaz, François; ... Frias, Miguel
unige:96959	Diabétologie	Jornayvaz, François;
unige:96920	Fasting glycaemia to simplify screening for gestational diabetes	Ryser, Joëlle; Jornayvaz, François; Rivest, R; Huhn, E A; ... Boulvain, Michel
unige:88489	Leptin as a Potential Regulator of FGF21	Asrih, Mohamed; Veyrat-Durebex, Christelle; Poher, Anne-Laure; Lyautey, Jacqueline; ... Jornayvaz, François
unige:96957	Low birth weight leads to obesity, diabetes and increased leptin levels in adults: the CoLaus study	Jornayvaz, François; Vollenweider, Peter; Bochud, Murielle; Mooser, Vincent; ... Marques-Vidal, Pedro
unige:96961	Place des nouveaux antidiabétiques dans la population gériatrique	Besse, Sarah; Besse, Arun; Jornayvaz, François;
unige:89990	Preserving of Postnatal Leptin Signaling in Obesity-Resistant Lou/C Rats following a Perinatal High-Fat Diet	Poher, Anne-Laure; Arsenijevic, Denis; Asrih, Mohamed; Dulloo, Abdul G; ... Veyrat-Durebex, Christelle
unige:96956	Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance	Popov, Violeta B; Jornayvaz, François; Akgul, Emin O; Kanda, Shoichi; ... Samuel, Varman T
unige:96962	Sécurité cardiovasculaire des antidiabétiques	Aline Roth, Pressl-Wenger; Jornayvaz, François;

2015

Scientific Articles

unige:96967	ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content	Camporez, João Paulo G; Kanda, Shoichi; Petersen, Max C; Jornayvaz, François; ... Shulman, Gerald I
unige:96966	Classification du diabète : vers une hétérogénéité croissante	Corcillo Vionnet, Antonella; Jornayvaz, François;
unige:96963	Edulcorants artificiels et diabète : faux amis ?	Tran, Christel; Jornayvaz, François;
unige:96965	Endocrine causes of nonalcoholic fatty liver disease	Marino, Laura; Jornayvaz, François;
unige:87951	Free Fatty Acids Impair FGF21 Action in HepG2 Cells	Asrih, Mohamed; Montessuit, Christophe Albert; Philippe, Jacques; Jornayvaz, François;
unige:96969	Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21	Camporez, João Paulo G; Asrih, Mohamed; Zhang, Dongyan; Kahn, Mario; ... Jornayvaz, François
unige:74395	Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue	Asrih, Mohamed; Altirriba Gutierrez, Jorge; Rohner-Jeanrenaud, Françoise; Jornayvaz, François;
unige:81147	Le diabète en 2015 : en augmentation constante, mais avec une offre thérapeutique qui s’élargit	Jornayvaz, François; Philippe, Jacques;